Industry Trends

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More




Strong Uptake for Site-Specific CTMS



By Deb Borfitz

December 14, 2009 | Economy-driven pressures to improve clinical trial efficiency, coupled with the growing need for electronic data capture (EDC), is giving a noteworthy boost to companies offering a clinical trial management system (CTMS) designed specifically for research sites, including those running as few as three studies concurrently. The newfound demand is a direct result of ongoing patient recruitment challenges, increased sponsor focus on costs and timelines, expanding trial complexity, and inefficient data management processes, says Maria Durkin, vice president and director of marketing and operations at Rochester, NY-based Bio-Optronics.

Currently, about 600 sites of every size and variety are using Clinical Conductor, the CTMS launched by Bio-Optronics two years ago. That’s up from 400 earlier this year, notes Durkin. “More sites have been proactively coming to us for answers… [to] help them recruit faster, run trials more effectively, reduce costs, and be more marketable to sponsors.”

Plano, Tex-based ClinTrial Works started selling its site-specific ClinTrial Works CTMS in September and president Angela Germany reports it has been “well-received by the industry.” Current clients consist of small and moderate sized sites, which has been the target.

With thousands of sites in the U.S. still relying on paper and pen or an Excel spreadsheet to manage trials, they’ll be no shortage of would-be customers for either company in the months ahead. For 15 years, StudyManager and Clinasyst were virtually the only players offering sites an information technology (IT) alternative.

CTMS allows sites to leverage data about protocols and patients, within a single site or across multiple ones, from one centralized location, says Durkin. Among the unique features of Clinical Conductor is the ability to quickly identify potential study subjects within an existing patient database, develop simple or detailed online pre-screening questionnaires, and manage the “complete enterprise workflow.” The system captures metrics to help sites market themselves to sponsors, automatically schedule patient visits per the protocol, and manage their finances. Clinical Conductor is integrated with QuickBooks, allowing sites to automate payment of patient stipends or any of their other financial obligations.

Twenty-five years of experience in health care, workflow, and IT differentiates Bio-Optronics as a company, and that expertise was used collaboratively with research sites to develop Clinical Conductor, says Durkin. Customer support is available 24/7 and web-based training is offered throughout the year, all at no extra charge. New releases come out multiple times a year and enhancements are driven by customer requests and evolving market needs. The latest version includes a project management module for milestone tracking.

Future editions of Clinical Conductor are expected to integrate with more enterprise IT systems inclusive of EDC as well as electronic medical record and health information systems. “New offerings will continue to improve collaboration across research boundaries,” Durkin says. Recent enhancements, including a physician portal for information sharing, and improved financial management tools, have piqued the interest of more academic sites.

Germany personally developed ClinTrial Works to give sites, including her own (Professional Research Network of Kansas), a more efficient way to self-manage. It’s purposefully designed to be “real flat and basic” and is priced to be financially feasible for small and newly established sites, she says. Rather than the more typical per-study fee, ClinTrial Works charges a flat monthly subscription fee—discounted 50% for sites doing fewer than ten studies annually—plus a single, upfront fee for unlimited training. At least some of that cost may be recouped directly from sponsors, who often allow a “technology fee” to be worked into study budgets.

Although Germany plans to “take it slow” to ensure site support for ClinTrial Works is top-notch, she’s still shooting to have at least 250 sites using the system by the end of 2010 “because it’s so user friendly.” Training, typically done online, takes no more than 90 minutes.

Click here to log in.

1 Comments

  • Avatar

    What are the monthly subscription and other fees for ClinTrial for sites doing <10 trials a year?

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





Sponsored Links

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .